Immunology and Microbiology
Severe Acute Respiratory Syndrome Vaccine
100%
SARS Coronavirus
100%
Newcastle Disease Virus
83%
Viral Vector
50%
Severe Acute Respiratory Syndrome
50%
Vaccination Policy
50%
RNA Virus
50%
interferon
50%
Mouse
33%
Viral Disease
33%
Virus Mutant
33%
Immunogenicity
33%
Vaccine Efficacy
33%
Pathogenicity
33%
Synthetic Vaccine
16%
Species Difference
16%
Innate Immune System
16%
Signal Transduction
16%
Coronavirinae
16%
Virus Attenuation
16%
Viral Protein
16%
Coronaviridae
16%
Alphavirus
16%
Replicon
16%
Keyphrases
Severe Acute Respiratory Syndrome
80%
Severe Acute Respiratory Syndrome Virus
80%
Recombinant Newcastle Disease Virus
57%
Newcastle Disease Vaccine
42%
RNA Virus
34%
Vaccination
34%
Virus
34%
Immunogenicity
22%
Protective Effect
22%
Reverse Genetics
22%
Attenuated Virus
14%
Coronaviridae Family
14%
Antiviral Drug Development
14%
Interferon Antagonist
14%
Innate Antiviral
14%
Recent Outbreaks
14%
Immunoprotective Effect
14%
Human Remains
14%
Attenuation
11%
Novel Virus
11%
M Protein
11%
Species Traits
11%
Tissue Tropism
11%
Virus Infection
11%
Type I Interferon Response
11%
Re-emergence
11%
Signaling Cascades
11%
Replicon
11%
Spike Protein
11%
Interferon-α (IFN-α)
11%
Signaling Pathway
11%
Specific Point
11%
High Virulence
11%
N Protein
11%
E Protein
11%
High Pathogenicity
11%
Coronavirus
11%
Cellular Innate Immune Response
11%
Antiviral State
11%
Viral Proteins
11%
Viral Infection
11%
Vaccine Development
11%
Alphavirus
11%
Pathogenicity
11%
Antiviral Activity
11%
Cellular Pathways
11%
Pre-existing Immunity
11%